GxP-compliant CI/CD for a pharma manufacturer

The client is a Swiss pharmaceutical manufacturer whose release process to validated systems was governed by GxP. In pharma, every change to a validated system must be evidenced, which makes releasing slow and paperwork-heavy.

The manual validation process behind each release had become a serious bottleneck on the pace of delivery.

Under GxP, every release to validated systems was a manual, months-long paperwork exercise that throttled delivery. The compliance overhead had become the dominant cost of shipping anything.

The evidence was assembled by hand after the fact, slow to produce and easy to get wrong. Manual assembly was both a delay and a risk.

The manufacturer needed to release far faster without weakening the validation the regulator depends on. Speed could not come at the expense of compliance: if anything, compliance had to get stronger.

We built computerised-system-validation directly into the pipeline, so validation is executed and evidenced automatically at every release rather than reconstructed later. Making compliance a product of the pipeline is what turned a months-long process into a fast one.

Each stage produces its own audit artefacts, making the pipeline itself the source of compliance evidence. The evidence is generated as work happens, not assembled afterward.

That turned a months-long manual process into a repeatable, fast one that is stronger, not weaker, on control, and we proved the approach on a lower-risk system before extending it across the estate. Confidence was built incrementally.